Acelyrin, Inc. (NASDAQ:SLRN – Get Rating) major shareholder Biopartners Fund Ii Westlake acquired 1,250,000 shares of the stock in a transaction that occurred on Tuesday, May 9th. The stock was acquired at an average cost of $18.00 per share, with a total value of $22,500,000.00. Following the completion of the purchase, the insider now owns […]
Acelyrin, Inc. (NASDAQ:SLRN – Get Rating) Director Beth C. Seidenberg acquired 60,000 shares of the stock in a transaction dated Tuesday, May 9th. The shares were bought at an average cost of $18.00 per share, with a total value of $1,080,000.00. Following the transaction, the director now directly owns 60,000 shares of the company’s stock, […]
Acelyrin, Inc. (NASDAQ:SLRN – Get Rating) insider Ronald Oyston purchased 1,000 shares of the company’s stock in a transaction dated Tuesday, May 9th. The shares were acquired at an average price of $18.00 per share, with a total value of $18,000.00. Following the transaction, the insider now owns 1,000 shares in the company, valued at […]
know more about the shooter because it can help us understand perhaps motive and what was going on in this person s mind. and that kind of information used to help prevent something else. sure. you know, involving someone else. right. and that is something, i think, we re going to learn in a short time. i also want to note i know a lot has been made slrn i in the last hour about why didn t police identify this individual at the press conference. chris combs, the special agent in charge of the fbi is well known in the fbi and in law enforcement as the guy who always insisted that and he started a campaign, this no name campaign in terms of mass shootings. he did not want shooters names in mass shootings. he just felt it gives them notoriety that they shouldn t have, and that has always been the concern here. so i think that is what we saw during that press conference is officials not wants to name him because they don t want to give him the notoriety, but i think that i ooh